Indaptus Therapeutics, Inc. approved amendments to its bylaws, addressing proxy rules, enhancing disclosure requirements, and designating exclusive forum for actions under the Securities Act.
AI Assistant
INDAPTUS THERAPEUTICS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.